ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.2914C>T (p.Arg972Trp)

gnomAD frequency: 0.00096  dbSNP: rs193922382
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000035542 SCV000052954 likely benign not specified 2023-10-02 criteria provided, single submitter clinical testing Variant summary: MYBPC3 c.2914C>T (p.Arg972Trp) results in a non-conservative amino acid change located in the Immunoglobulin-like domain (IPR007110) of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 185800 control chromosomes, predominantly at a frequency of 0.0037 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3.7-fold of the estimated maximal expected allele frequency for a pathogenic variant in MYBPC3 causing Cardiomyopathy phenotype (0.001), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.2914C>T has been reported in the literature in individuals affected with Cardiomyopathy without strong evidence of causality (Bick_2012, Burstein_2021). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22958901, 32746448). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035542 SCV000059192 likely benign not specified 2012-07-20 criteria provided, single submitter clinical testing p.Arg972Trp in exon 28 of MYBPC3: This variant is not expected to have clinical significance because it has been identified in 0.3% (11/3792) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS). In addition, one mammalian species (elephant) ca rries a tryptophan (Trp; this variant) at this position, despite high nearby ami no acid conservation, further supporting a benign role. A modifying effect cann ot be ruled out.
GeneDx RCV001529595 SCV000207991 likely benign not provided 2021-04-29 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22958901)
Ambry Genetics RCV000245670 SCV000318294 likely benign Cardiovascular phenotype 2018-08-02 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV000466462 SCV000546448 likely benign Hypertrophic cardiomyopathy 2024-01-20 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000770332 SCV000901766 benign Cardiomyopathy 2023-05-03 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000035542 SCV001157731 likely benign not specified 2019-03-03 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000770332 SCV001353201 likely benign Cardiomyopathy 2018-11-30 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001529595 SCV001743294 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV001529595 SCV001919942 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001529595 SCV001955628 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001529595 SCV001967173 likely benign not provided no assertion criteria provided clinical testing
Cohesion Phenomics RCV000466462 SCV003800598 benign Hypertrophic cardiomyopathy 2022-10-10 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.